title: Structures of darunavir-resistant HIV-1 protease mutant reveal atypical binding of darunavir to wide open flaps.
abstract: The molecular basis for high resistance to clinical inhibitors of HIV-1 protease (PR) was examined for the variant designated PRP51 that was selected for resistance to darunavir (DRV). High resolution crystal structures of PRP51 with the active site D25N mutation revealed a ligand-free form and an inhibitor-bound form showing a unique binding site and orientation for DRV. This inactivating mutation is known to increase the dimer dissociation constant and decrease DRV affinity of PR. The PRP51-D25N dimers were in the open conformation with widely separated flaps, as reported for other highly resistant variants. PRP51-D25N dimer bound two DRV molecules and showed larger separation of 8.7 Å between the closest atoms of the two flaps compared with 4.4 Å for the ligand-free structure of this mutant. The ligand-free structure, however, lacked van der Waals contacts between Ile50 and Pro81' from the other subunit in the dimer, unlike the majority of PR structures. DRV is bound inside the active site cavity; however, the inhibitor is oriented almost perpendicular to its typical position and exhibits only 2 direct hydrogen bond and two water-mediated interactions with atoms of PRP51-D25N compared with 11 hydrogen bond interactions seen for DRV bound in the typical position in wild-type enzyme. The atypical location of DRV may provide opportunities for design of novel inhibitors targeting the open conformation of PR drug-resistant mutants.
authors.affiliation: Department of Chemistry, ‡Department of Biology, and §Department of Computer Science, Georgia State University , Atlanta, Georgia 30303, United States.
authors.forename: Ying
authors.initials: Y
authors.lastname: Zhang
authors.forename: Yu-Chung E
authors.initials: YC
authors.lastname: Chang
authors.forename: John M
authors.initials: JM
authors.lastname: Louis
authors.forename: Yuan-Fang
authors.initials: YF
authors.lastname: Wang
authors.forename: Robert W
authors.initials: RW
authors.lastname: Harrison
authors.forename: Irene T
authors.initials: IT
authors.lastname: Weber
mesh_terms: D000595:Amino Acid Sequence; D001665:Binding Sites; D020134:Catalytic Domain; D018360:Crystallography, X-Ray; D000069454:Darunavir; D024882:Drug Resistance, Viral; D016333:HIV Protease / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism; D017320:HIV Protease Inhibitors / Q000378:metabolism*; D006801:Humans; D006860:Hydrogen Bonding; D008958:Models, Molecular; D008969:Molecular Sequence Data; D009154:Mutation / Q000235:genetics; D011487:Protein Conformation; D017386:Sequence Homology, Amino Acid; D013449:Sulfonamides / Q000378:metabolism*
chemical_list: D017320:HIV Protease Inhibitors; D013449:Sulfonamides; D016333:HIV Protease; C514803:p16 protease, Human immunodeficiency virus 1; D000069454:Darunavir
references.citation: J Virol. 2004 Nov;78(21):12012-21
references.pmid: 15479840
references.citation: Adv Pharmacol. 2000;49:111-46
references.pmid: 11013762
references.citation: Antimicrob Agents Chemother. 2003 Oct;47(10):3123-9
references.pmid: 14506019
references.citation: Methods Enzymol. 1997;276:307-26
references.pmid: 27754618
references.citation: Protein Sci. 2010 Nov;19(11):2055-72
references.pmid: 20737578
references.citation: Nat Struct Biol. 1999 Sep;6(9):868-75
references.pmid: 10467100
references.citation: Proc Natl Acad Sci U S A. 2011 May 31;108(22):9072-7
references.pmid: 21576495
references.citation: Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32
references.pmid: 15572765
references.citation: J Virol. 2004 Mar;78(6):3123-32
references.pmid: 14990731
references.citation: Biochimie. 1991 Nov;73(11):1391-6
references.pmid: 1799632
references.citation: J Mol Biol. 2006 Oct 13;363(1):161-73
references.pmid: 16962136
references.citation: J Biol Chem. 2008 May 9;283(19):13459-70
references.pmid: 18281688
references.citation: FEBS J. 2010 Sep;277(18):3699-714
references.pmid: 20695887
references.citation: Acta Crystallogr D Biol Crystallogr. 1997 May 1;53(Pt 3):240-55
references.pmid: 15299926
references.citation: AIDS Res Hum Retroviruses. 2008 Mar;24(3):379-88
references.pmid: 18327986
references.citation: J Virol. 2009 Sep;83(17):8810-8
references.pmid: 19535439
references.citation: Annu Rev Biochem. 1993;62:543-85
references.pmid: 8352596
references.citation: J Med Chem. 2013 Feb 14;56(3):1074-83
references.pmid: 23298236
references.citation: Biochem Biophys Res Commun. 2013 Jul 26;437(2):199-204
references.pmid: 23792096
references.citation: Viruses. 2009 Dec;1(3):1110-36
references.pmid: 21994585
references.citation: Biochemistry. 2012 Apr 3;51(13):2819-28
references.pmid: 22404139
references.citation: Protein Sci. 2012 Mar;21(3):339-50
references.pmid: 22238126
references.citation: J Med Chem. 2008 Aug 14;51(15):4839-43
references.pmid: 18598016
references.citation: J Mol Biol. 2004 Apr 23;338(2):341-52
references.pmid: 15066436
references.citation: Protein Sci. 2009 Dec;18(12):2442-53
references.pmid: 19798742
references.citation: J Mol Biol. 2005 Dec 9;354(4):789-800
references.pmid: 16277992
references.citation: Acta Crystallogr D Biol Crystallogr. 2007 Aug;63(Pt 8):866-75
references.pmid: 17642513
references.citation: Angew Chem Int Ed Engl. 2012 Feb 20;51(8):1778-802
references.pmid: 22290878
references.citation: Biochemistry. 1994 Aug 16;33(32):9405-13
references.pmid: 8068616
references.citation: J Virol. 2010 Nov;84(22):11961-9
references.pmid: 20810732
references.citation: J Chem Theory Comput. 2012 Oct 9;8(10):3452-3462
references.pmid: 23144597
references.citation: Biochemistry. 2012 Oct 9;51(40):7813-5
references.pmid: 23009326